Filing Details
- Accession Number:
- 0001171843-17-007734
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-18 17:11:00
- Reporting Period:
- 2017-12-15
- Accepted Time:
- 2017-12-18 17:11:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1359931 | Proteon Therapeutics Inc | PRTO | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1619834 | Keith Steven Burke | C/O Proteon Therapeutics 200 West Street Waltham MA 02451 | Svp And Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-12-15 | 12,000 | $1.88 | 117,535 | No | 4 | P | Direct | |
| Common Stock | Disposition | 2017-12-15 | 3,334 | $0.00 | 114,201 | No | 5 | G | Direct | |
| Common Stock | Disposition | 2017-12-15 | 3,333 | $0.00 | 110,868 | No | 5 | G | Direct | |
| Common Stock | Disposition | 2017-12-15 | 3,333 | $0.00 | 107,535 | No | 5 | G | Direct | |
| Common Stock | Acquisiton | 2017-12-15 | 3,333 | $0.00 | 8,333 | No | 5 | G | Indirect | See footnote |
| Common Stock | Acquisiton | 2017-12-15 | 3,333 | $0.00 | 11,666 | No | 5 | G | Indirect | See footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 5 | G | Direct | |
| No | 5 | G | Direct | |
| No | 5 | G | Direct | |
| No | 5 | G | Indirect | See footnote |
| No | 5 | G | Indirect | See footnote |
Footnotes
- The purchase price of $1.88 is reflective of the weighted average purchase price of all transactions reported on this line. The prices for the transactions reported on this line range from $1.875 to $1.9. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- This transaction involved a gift of securities by the reporting person to the William Conroy Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose.
- This transaction involved a gift of securities by the reporting person to the Timothy Andrew Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose.
- This transaction involved a gift of securities by the reporting person to the Steven Edward Burke Irrevocable Trust u/a 11/15/2000, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose.
Billionaire Hedge Funds
